Good Clinical Practice: A Question & Answer Reference Guide 2024-2025

Cover Page Table of Contents Introduction Section 1: GCP Regulations, Standards, and Guidelines for Clinical Research Section 2: Investigators/Sites Section 3: Study Sponsors and Investigator Site Monitoring Section 4: Informed Consent Section 5: Source Data/Documentation Section 6: Clinical Trial Protocols/Protocol Changes/Protocol Violations Section 7: Institutional Review Boards and Ethics Committees Section 8: Drug/Study Safety and Safety Reporting Section 9: Quality Assurance & Auditing Section 10: Regulatory Inspections Section 11: Clinical Data Management Section 12: Computerized Systems, Electronic Records, and e-Data Integrity Section 13: Patient Recruitment and Clinical Trial Diversity Section 14: Conflicts of Interest/Financial Disclosure Section 15: The HIPAA Privacy Rule and FDA-Regulated Clinical Trials Section 16: Investigational Medicinal Product Management Section 17: Fraud, Negligence, and Regulatory Non-Compliance Section 18: The Trial Master File Section 19: Risk Based Quality Management/Quality by Design Section 20: Impact of World Events on Clinical Trial Management Section 21: Decentralized Clinical Trials Section 22: European Privacy and Data Protection/GDPR Appendix: GCP Compliance Statistics and Trends Index